Kirsten M. Kliphouse - 12 Oct 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kirsten M. Kliphouse
Issuer symbol
LH
Transactions as of
12 Oct 2023
Net transactions value
$0
Form type
4
Filing time
16 Oct 2023, 08:43:51 UTC
Previous filing
07 Aug 2023
Next filing
30 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +372 372 12 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -372 -28% $0.000000 947 12 Oct 2023 Common Stock 372 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vested fully on October 12, 2023.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 137 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc.